Press Release Archives - Page 2 of 5

SparingVision Presents New Data on SPVN20 Program at ASGCT 2023 First oral presentation on SPVN20…

SparingVision to Highlight Progress of its SPVN20 Program in oral presentation at ASGCT 2023 Paris,…

SparingVision Presents Progress of its Lead Gene Therapy Program SPVN06 at ARVO 2023 Paris, April…

SparingVision receives final tranche payment from the European Investment Council as part of the EIC…

SparingVision to Highlight Progress of its Lead Gene Therapy Program SPVN06 and Research on Retinitis…

SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…

SparingVision Conference Participation in H1 2023 Paris, January 31, 2023 – SparingVision (“the Company”), a…

SparingVision s lead asset SPVN06 clears IND application in the US for the treatment of…

SparingVision to Participate in Upcoming Scientific and Medical Conferences Paris, October 25, 2022 – SparingVision…

Cookie	Duration	Description
__cf_bm	1 hour	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management. Further information: https://developers.cloudflare.com/fundamentals/reference/policies-compliances/cloudflare-cookies/#__cf_bm-cookie-for-cloudflare-bot-products
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Analytics" category.
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Necessary" category.
CookieLawInfoConsent	6 months	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	1 year	The GDPR Cookie Consent plugin sets the cookie to store whether or not the user has consented to use cookies. It does not store any personal data.